Intracytoplasmic morphologically selected sperm injection benefits for patients with oligoasthenozoospermia according to the 2010 World Health Organization reference values

dc.contributorFertil Assisted Fertilizat Ctr
dc.contributorEduc & Res Ctr Assisted Reprod
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:35:25Z
dc.date.available2014-05-20T13:35:25Z
dc.date.created2014-05-20T13:35:25Z
dc.date.issued2011-06-01
dc.identifierFertility and Sterility. New York: Elsevier B.V., v. 95, n. 8, p. 2711-2714, 2011.
dc.identifier0015-0282
dc.identifierhttp://hdl.handle.net/11449/12180
dc.identifier10.1016/j.fertnstert.2011.03.003
dc.identifierWOS:000292034100105
dc.description.abstractThe comparison between the outcomes of intracytoplasmic morphologically selected sperm injection performed in couples with male factor infertility according to the World Health Organization guidelines from 1999 and 2010 was the objective of this study. Our results suggest that the sperm selection under high magnification results in improved treatment outcomes in patients with oligoasthenoteratozoospermia, according to the new World Health Organization guidelines. (Fertil Steril (R) 2011;95:2711-4. (C)2011 by American Society for Reproductive Medicine.)
dc.languageeng
dc.publisherElsevier B.V.
dc.relationFertility and Sterility
dc.relation4.803
dc.relation2,250
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectICSI
dc.subjectmale factor infertility
dc.subjectIMSI
dc.subjectoligoasthenozoospermia
dc.subjectsperm morphology
dc.titleIntracytoplasmic morphologically selected sperm injection benefits for patients with oligoasthenozoospermia according to the 2010 World Health Organization reference values
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución